Anouk Achten

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Electrocardiogram-Based Deep Learning to Prioritize Testing for Transthyretin Amyloid Cardiomyopathy.

Electrocardiogram-Based Deep Learning to Prioritize Testing for Transthyretin Amyloid Cardiomyopathy.

Journal: JAMA

Published: August 28, 2026

Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI.

Vutrisiran Treatment and Changes in Cardiac Parameters and Amyloid Burden Assessed by Cardiovascular MRI.

Journal: JAMA cardiology

Published: August 12, 2026

Cardiac screening of amyloid TTR pathogenic variant carriers: complementary value of echocardiographic global longitudinal strain imaging and bone scintigraphy.

Cardiac screening of amyloid TTR pathogenic variant carriers: complementary value of echocardiographic global longitudinal strain imaging and bone scintigraphy.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: October 29, 2025

Myocardial Amyloid Burden in Transthyretin Amyloidosis.

Myocardial Amyloid Burden in Transthyretin Amyloidosis.

Journal: Journal of the American College of Cardiology

Published: September 22, 2025

Associations of Serially Measured NT-proBNP With Incident Heart Failure With Reduced and Preserved Ejection Fraction.

Associations of Serially Measured NT-proBNP With Incident Heart Failure With Reduced and Preserved Ejection Fraction.

Journal: Mayo Clinic proceedings

Published: June 28, 2025

Time to screen: rationale and roadmap for HFpEF screening in individuals with obesity.

Time to screen: rationale and roadmap for HFpEF screening in individuals with obesity.

Journal: Heart failure reviews

Published: June 16, 2025

Sex-specific performance of clinical diagnostic algorithms for HFpEF across two independent cohorts.

Sex-specific performance of clinical diagnostic algorithms for HFpEF across two independent cohorts.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: May 22, 2025

Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fraction.

Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fraction.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: March 20, 2025

Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction.

Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction.

Journal: Cardiovascular diabetology

Published: February 20, 2025

Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?

Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?

Journal: Expert review of cardiovascular therapy

Published: February 10, 2025

The diagnostic yield of an elaborate workup for comorbidities in a real-life HFpEF outpatient population.

The diagnostic yield of an elaborate workup for comorbidities in a real-life HFpEF outpatient population.

Journal: European journal of preventive cardiology

Published: January 30, 2025

Immuno-haemostatic dysregulation in heart failure with preserved ejection fraction.

Immuno-haemostatic dysregulation in heart failure with preserved ejection fraction.

Journal: ESC heart failure

Published: January 30, 2025

Showing 1-12 of 25

Last Updated: 09/26/2026